← Open Payments lookup

ABIOLA GRANT: Open Payments

NPI 1508405044 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,831 in 131 payments from 23 companies in 2025. Trend: 2023 $1,243 · 2024 $1,883 · 2025 $2,831

Food & beverage: $2,762Education: $69
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP34$799
ABBVIE INC.34$537
Otsuka America Pharmaceutical, Inc.20$467
GlaxoSmithKline, LLC.11$196
Amgen Inc.4$186
Astellas Pharma US Inc2$85
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$84
Axsome Therapeutics, Inc.3$75
Novo Nordisk Inc2$48
Inspire Medical Systems, Inc.2$44

Products named: REXULTI, VRAYLAR, FARXIGA, BREZTRI, Repatha, NUCALA, TRELEGY ELLIPTA, XIFAXAN.

Industry payments across CT — which companies pay providers there.